Abstract-The Unified Parkinson's Disease Rating Scale (UPDRS) is a widely applied index of disease severity. Our objective was to assess the utility of UPDRS for predicting peak aerobic capacity (VO 2 peak) and ambulatory function. Participants (n = 70) underwent evaluation for UPDRS (Total and Motor ratings), VO 2 peak, 6-minute walk distance (6MW), and 30-foot self-selected walking speed (SSWS). Using regression, we determined the extent to which the Total and Motor UPDRS scores predicted each functional capacity measure after adjusting for age and sex. We also tested whether adding the Hoehn and Yahr scale (H-Y) to the model changed predictive power of the UPDRS. Adjusted for age and sex, both the Total UPDRS and Motor UPDRS subscale failed to predict VO 2 peak. The Total UPDRS did weakly predict 6MW and SSWS (both p < 0.05), but the Motor UPDRS subscale did not predict these ambulatory function tests. After adding H-Y to the model, Total UPDRS was no longer an independent predictor of 6MW but remained a predictor of SSWS. We conclude that Total and Motor UPDRS rating scales do not predict VO 2 peak, but that a weak relationship exists between Total UPDRS and measures of ambulatory function.
INTRODUCTION
The Unified Parkinson's Disease Rating Scale (UPDRS) is the most widely applied rating instrument for Parkinson disease (PD) [1] [2] . The Total UPDRS score includes 31 items contributing to three subscales: (I) Mentation, Behavior, and Mood; (II) Activities of Daily Living; and (III) Motor Examination [2] . The UPDRS does not assess general cardiovascular fitness and provides only limited information on functional performance relevant to daily activities, although this information would facilitate clinical decision-making. Therefore, there is value in determining the predictive power of the UPDRS for more time-consuming and resource-intensive measures such as peak aerobic capacity (VO 2 peak) and ambulatory function.
The UPDRS includes an examination of extrapyramidal motor function and has been shown to predict physical performance measures with a strong balance component, such as Berg Balance and the functional reach tests [3] [4] . Further, previous studies have shown that the UPDRS associates with daily function [3] [4] [5] and is sensitive to change over time [1] and across rehabilitation interventions [5] [6] . However, uncertainty remains regarding the extent to which UPDRS predicts important aspects of function associated with ambulatory function, considering that prior investigations have failed to observe associations between UPDRS and 6-minute walk distance (6MW) [7] or between UPRDS and submaximal oxygen consumption during treadmill walking [8] . Importantly, no studies have evaluated whether the UPDRS predicts VO 2 peak, a gold standard objective physical performance measure of cardiovascular fitness. Hence, the current study sought to enhance understanding about whether UPDRS predicts VO 2 peak and ambulatory function by examining the relationship of Total and Motor UPDRS with VO 2 peak, 6MW, and floor walking speed. Based on limited prior work, we hypothesized that UPDRS would fall short of predicting VO 2 peak and ambulatory function, both of which have an endurance requirement.
METHODS

Subjects
Recruits for this cross-sectional study came from the University of Maryland Parkinson's Disease Center and the Baltimore Department of Veterans Affairs (VA) Medical Center. All had volunteered to participate in a randomized exercise intervention trial designed specifically for PD patients. Entry criteria for this study have been described previously in Katzel et al. [9] and are included in the Appendix (available online only).
All tests of VO 2 peak and ambulatory function were conducted on separate days to avoid the confounding effects of fatigue. The tests were done in the same order for all subjects. The treadmill VO 2 peak test was done 1 wk after assessment of ambulatory function (self-selected walking speed [SSWS] and 6MW). Further, all study evaluations (rating scales, VO 2 peak, and ambulatory function testing) were conducted soon after medication intake (<3 h) while the subjects were "on." When required, subjects took an additional dose to maintain the "on" state during evaluation.
Unified Parkinson's Disease Rating Scale Evaluation
The UPDRS scale was scored by a single neurologist to avoid the confounding effects of interrater variability.
The evaluator is a board-certified neurologist and specialist in PD who is certified in the administration of the UPDRS. The UPDRS Total score was computed as the sum of UPDRS subscales I, II, and III.
Peak Aerobic Capacity
Treadmill testing was always conducted during the early afternoon hours when subjects were "on" soon after taking medication. Exercise tests were terminated according to American College of Sports Medicine guidelines [10] . Gait belts and other safety precautions protected against falls resulting from loss of balance. There were no falls during the treadmill VO 2 peak tests or assessments of ambulatory function. Subjects were instructed to use as little handrail support as possible during the treadmill tests.
Both the treadmill testing (VO 2 peak) and overground ambulatory function testing (SSWS and 6MW) protocols have been previously described for this study population in articles by Katzel et al. [9, 11] , and those descriptions are provided in the Appendix (available online only).
Statistical Methods
Separate multiple regressions were used to evaluate UPDRS as a predictor of each of the three performance measures (VO 2 peak, SSWS, and 6MW). For each outcome, a separate analysis for both Total UPDRS and Motor UPDRS was run. All analyses were originally adjusted for age and sex. The models were then rerun after adding a simpler measure of disease progression (Hoehn and Yahr scale [H-Y]) to determine whether the predictive strength of the UPDRS remained. H-Y is a clinical staging instrument that is even more widely utilized than UPDRS. Therefore, addition of H-Y to the model answers an important question related to whether UPDRS adds anything to the functional information obtained from the more routine H-Y scale. Probability values 0.05 were considered significant.
RESULTS
Subjects
A total of 70 participants were studied. Fewer observations (n = 64) were available for the 6MW analysis because of missed tests. Participants were predominantly Caucasian (90%) and male (71%) and had a mean age of 65 yr ( Table 1) . The mean H-Y score of 2.2 was indicative of a mild to moderately impaired population of PD participants. The means for SSWS, 6MW, and VO 2 peak were also consistent with mild to moderate disability. The diversity of disability is captured by the range of scores for the total UPDRS (15-89) and H-Y (1.5-3.0) ( Table 1) .
Unified Parkinson's Disease Rating Scale as Predictor of Peak Aerobic Capacity
Neither Total UPDRS (0.024 ± 0.034, β ± standard error [SE] , p = 0.492) nor Motor UPDRS (0.038 ± 0.048, β ± SE, p = 0.429) were significant predictors of VO 2 peak after correcting for age and sex ( Table 2 ). Both age (0.190 ± 0.042, p < 0.001) and sex (3.821 ± 0.986, p < 0.001) were independent predictors of VO 2 peak. For each year of age, VO 2 dropped by about 0.2 mL/kg/min, and female participants with PD had VO 2 peak measurements that were on average 3.8 mL/kg/min lower than males. Neither H-Y alone nor H-Y combined with the UPDRS measures was a significant predictor of VO 2 peak.
Unified Parkinson's Disease Scale as Predictor of Ambulatory Function
When UPDRS ratings were evaluated for prediction of ambulatory UPDRS was an independent predictor for 6MW (2.122 ± 0.884, β ± SE, p = 0.020) and SSWS (0.005 ± 0.002, p = 0.008) after adjusting for age and sex ( Table 3) . Total UPDRS, age, and sex explained 16 percent of the variance in 6MW and 24 percent of the variance in SSWS, indicating a weak but statistically significant relationship (Figure) . Conversely, Motor UPDRS was not a significant predictor of either SSWS or 6MW, adjusting for age and sex. For both ambulatory function tests, age but not sex was a significant independent predictor. When H-Y score was added to the model, the Total UPDRS was no longer a significant independent predictor of 6MW, but the independent relationship between Total UPDRS and SSWS was retained (p = 0.046) ( 
DISCUSSION
Our results show that neither the Total nor Motor UPDRS predicts VO 2 peak in mild to moderate PD. Total UPDRS but not Motor UPDRS was found to weakly predict ambulatory function. These findings extend the work of previous investigations on the clinical and functional significance of UPDRS ratings [3, [12] [13] .
The UPDRS is the most common instrument used to track PD severity and is widely considered the gold standard for evaluation of PD in both clinical and research settings [1] [2] . The UPDRS has attained this status based on both its reliability [14] [15] [16] and sensitivity to change over time [6, 17] . Nonetheless, the relationship between UPDRS ratings and progression of disability is not fully understood [18] [19] . The ability of the UPDRS to predict performance on quantitative tests of physical function has also not been fully established [3] . Our study shows that UPDRS is not associated with VO 2 peak, a performance measure relevant to cardiovascular and metabolic health as well as general functional capacity. Items in the UPDRS focus predominantly on the motor features of PD including bradykinesia, rigidity, and tremor [1] [2] . Nonmotor features of PD such as cognitive impairment, autonomic dysfunction, depression, and sleep disorders have received increasing attention in recent years [20] [21] and may contribute to variations in functional status. Interestingly, none of the items on the UPDRS assess the level of physical activity or endurance.
The UPDRS has been shown to predict physical performance measures with a strong balance component. For example, Tanji et al. compared ratings on the Berg Balance Scale and Functional Reach tests with Total and Motor UPDRS in 79 participants with a range of PD severity [3] . The results showed relatively strong correlations between UPDRS ratings and these measures of physical performance. Similarly, Brusse et al. found associations between the UPDRS and tests of balance, but failed to observe associations with ambulatory function [4] . They concluded that the single item of gait assessment in the Motor UPDRS (item 29) is inadequate to reflect walking performance [4] . This point may also be relevant to the weak performance of the UPDRS in predicting the ambulatory function and VO 2 peak measures in this study. Hence, previous studies indicate that the UPDRS may be a decent predictor of short physical performance measures with a strong balance component, but our results and others cast doubt on its utility for predicting ambulatory f unction and VO 2 peak performance, which requires sustained effort and a degree of endurance. Although studies have shown that the UPDRS is correlated with community ambulation patterns as measured by step activity monitoring [5] , the distance walked over the course of a day in the community is a different aspect of function than measures of ambulatory function and VO 2 peak obtained during formal laboratory testing. This is based on the higher levels of effort required for the laboratory tests. Both our findings and those of Falvo and Earhart [7] demonstrate that the UPDRS is not an independent predictor of 6MW when age and H-Y are added to the regression model.
The absence of an association between UPDRS and VO 2 peak observed in this study is partially supported by previous studies measuring VO 2 in PD. Canning et al. showed that VO 2 peak during cycle ergometry was not related to disease severity as assessed by H-Y staging [22] . Additionally, Christiansen et al. measured submaximal VO 2 during treadmill walking in PD (2.3 mph, 0 grade) and found that VO 2 was not correlated with Total UPDRS [8] . In combination with our results, it is reasonable to conclude that, in patients with mild to moderate PD, the UPDRS does not reflect either peak or submaximal aerobic performance.
Limitations of this study include the failure to study the full range of PD severity. Because we studied subjects with mild to moderate impairment (H-Y 1.5-3 while "on," mean 2.2 ± 0.4), our results may not be generalizable to the full spectrum of disease severity. Floor effects may limit sensitivity of the UPDRS in milder stages of the disease [1] . In addition to studying a broader range of disease severity, future studies should compare UPDRS with a larger battery of objective functional outcome tests. In this study, the majority of patients (57%) did not experience motor fluctuations, while 43 percent had fluctuations. There is no way to completely eliminate potential effects from varying medication levels. However, we attempted to proactively address this by performing exercise and study evaluations while the subjects were within 3 h of antiparkinsonian medication administration. If participants perceived that their medications were wearing off, our protocol permitted administration of an additional dose of antiparkinsonian medication, but this was not necessary during the study.
CONCLUSIONS
To summarize, the results shed additional light on the functional and clinical relevance of the UPDRS. The data show that PD severity assessed by the UPDRS Motor Examination subscale does not predict VO 2 peak or ambulatory function (6MW, SSWS). Further, Total UPDRS does not predict VO 2 peak but does independently predict SSWS, albeit modestly. Although there was a weak association between 6MW and Total UPDRS, the relationship disappeared after adding H-Y to the model. Lack of association with VO 2 peak may partly be a function of the underemphasis of UPDRS items on ambulatory function and associated elements of endurance. The UPDRS will continue to be widely used in assessing disease progression and the effectiveness of neuroprotective agents and for therapeutic decision-making by clinicians [2, 13] . Hence, increased understanding about the scale's limitations in predicting results on ambulatory function and VO 2 peak tests is important. Future attempts at revising the UPDRS scale should consider components related to sustained activity and endurance.
